Fucikova, Jitka

Detection of immunogenic cell death and its relevance for cancer therapy

Fucikova, J., Kepp, O., Kasikova, L., Petroni, G., Yamazaki, T., Liu, P., Zhao, L., Spisek, R., Kroemer, G., & Galluzzi, L. (2020) · Cell Death & Disease

Immunotherapy and Immune ResponsesCell death mechanisms and regulation

Cited by 1,138

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy

Adkins, I., Fucikova, J., Garg, A. D., Agostinis, P., & Špíšek, R. (2014) · OncoImmunology

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 200

Prognostic and predictive value of DAMPs and DAMP-associated processes in cancer

Fucikova, J., Moserova, I., Urbanova, L., Bezu, L., Kepp, O., Cremer, I., Salek, C., Strnad, P., Kroemer, G., Galluzzi, L., et al. (2015) · Frontiers in Immunology

Immunotherapy and Immune ResponsesImmune Response and Inflammation

Cited by 159

Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients

Rodriguez-Ruiz, M. E., Buqué, A., Hensler, M., Chen, J., Bloy, N., Petroni, G., Sato, A., Yamazaki, T., Fucikova, J., & Galluzzi, L. (2019) · OncoImmunology

Cell death mechanisms and regulationCancer Immunotherapy and Biomarkers

Cited by 147

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Buqué, A., Bloy, N., Perez-Lanzón, M., Iribarren, K., Humeau, J., Pol, J. G., Levesque, S., Mondragon, L., Yamazaki, T., Sato, A., et al. (2020) · Nature Communications

Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies

Cited by 138

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

Fucikova, J., Truxova, I., Hensler, M., Becht, E., Kasikova, L., Moserova, I., Vosahlikova, S., Klouckova, J., Church, S. E., Cremer, I., et al. (2016) · Blood

Acute Myeloid Leukemia ResearchImmunotherapy and Immune Responses

Cited by 135

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

Kasikova, L., Hensler, M., Truxova, I., Skapa, P., Laco, J., Belicova, L., Praznovec, I., Vosahlikova, S., Halaska, M. J., Brtnicky, T., et al. (2019) · Journal for ImmunoTherapy of Cancer

Ovarian cancer diagnosis and treatmentImmunotherapy and Immune Responses

Cited by 79

Trial watch: immune checkpoint blockers for cancer therapy

Vanpouille-Box, C., Lhuillier, C., Bezu, L., Aranda, F., Yamazaki, T., Kepp, O., Fucikova, J., Spisek, R., Demaria, S., Formenti, S. C., et al. (2017) · OncoImmunology

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 73

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients

Truxova, I., Kasikova, L., Salek, C., Hensler, M., Lysak, D., Holicek, P., Bilkova, P., Holubova, M., Chen, X., Mikyskova, R., et al. (2020) · Haematologica

Immune Cell Function and InteractionAcute Myeloid Leukemia Research

Cited by 56

Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial

Cibula, D., Rob, L., Mallmann, P., Knapp, P., Klat, J., Chovanec, J., Minar, L., Melichar, B., Hein, A., Kieszko, D., et al. (2021) · Gynecologic Oncology

Ovarian cancer diagnosis and treatmentImmunotherapy and Immune Responses

Cited by 52

Apoptotic caspases cut down the immunogenicity of radiation

Buqué, A., Rodriguez-Ruiz, M. E., Fucikova, J., & Galluzzi, L. (2019) · OncoImmunology

Cell death mechanisms and regulationImmunotherapy and Immune Responses

Cited by 28